Comparison of drug-eluting stents and drug-coated balloon for the treatment of drug-eluting coronary stent restenosis: A randomized RESTORE trial
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Wong, Yiu Tung Anthony | - |
dc.contributor.author | Kang, Do-Yoon | - |
dc.contributor.author | Lee, Jin Bae | - |
dc.contributor.author | Rha, Seung-Woon | - |
dc.contributor.author | Hong, Young Joon | - |
dc.contributor.author | Shin, Eun-Seok | - |
dc.contributor.author | Her, Sung-Ho | - |
dc.contributor.author | Nam, Chang Wook | - |
dc.contributor.author | Chung, Woo-Young | - |
dc.contributor.author | Kim, Moo Hyun | - |
dc.contributor.author | Lee, Cheol Hyun | - |
dc.contributor.author | Lee, Pil Hyung | - |
dc.contributor.author | Ahn, Jung-Min | - |
dc.contributor.author | Kang, Soo-Jin | - |
dc.contributor.author | Lee, Seung-Whan | - |
dc.contributor.author | Kim, Young-Hak | - |
dc.contributor.author | Lee, Cheol Whan | - |
dc.contributor.author | Park, Seong-Wook | - |
dc.contributor.author | Park, Duk-Woo | - |
dc.contributor.author | Park, Seung-Jung | - |
dc.date.accessioned | 2021-09-02T14:43:16Z | - |
dc.date.available | 2021-09-02T14:43:16Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2018-03 | - |
dc.identifier.issn | 0002-8703 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/77234 | - |
dc.description.abstract | Background This study sought to evaluate the optimal treatment for in-stent restenosis (ISR) of drug-eluting stents (DESs). Methods This is a prospective, multicenter, open-label, randomized study comparing the use of drug-eluting balloon (DEB) versus second-generation everolimus-eluting stent for the treatment of DES ISR. The primary end point was in-segment late loss at 9-month routine angiographic follow-up. Results A total of 172 patients were enrolled, and 74 (43.0%) patients underwent the angiographic follow-up. The primary end point was not different between the 2 treatment groups (DEB group 0.15 +/- 0.49 mm vs DES group 0.19 +/- 0.41 mm, P=.54). The secondary end points of in-segment minimal luminal diameter (MLD) (1.80 +/- 0.69 mm vs 2.09 +/- 0.46 mm, P=.03), in-stent MLD (1.90 +/- 0.71 mm vs 2.29 +/- 0.48 mm, P=.005), in-segment percent diameter stenosis (34% +/- 21% vs 26% +/- 15%, P=.05), and in-stent percent diameter stenosis (33% +/- 21% vs 21% +/- 15%, P=.002) were more favorable in the DES group. The composite of death, myocardial infarction, or target lesion revascularization at 1 year was comparable between the 2 groups (DEB group 7.0% vs DES group 4.7%, P=.51). Conclusions Treatment of DES ISR using DEB or second-generation DES did not differ in terms of late loss at 9-month angiographic follow-up, whereas DES showed better angiographic results regarding minimal MLD and percent diameter stenosis. Both treatment strategies were safe and effective up to 1 year after the procedure. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | MOSBY-ELSEVIER | - |
dc.subject | BARE-METAL | - |
dc.subject | CLINICAL-TRIAL | - |
dc.subject | SIROLIMUS | - |
dc.subject | IMPLANTATION | - |
dc.subject | ARTERY | - |
dc.subject | REVASCULARIZATION | - |
dc.subject | METAANALYSIS | - |
dc.subject | ANGIOPLASTY | - |
dc.subject | MULTICENTER | - |
dc.subject | CATHETER | - |
dc.title | Comparison of drug-eluting stents and drug-coated balloon for the treatment of drug-eluting coronary stent restenosis: A randomized RESTORE trial | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Rha, Seung-Woon | - |
dc.identifier.doi | 10.1016/j.ahj.2017.11.008 | - |
dc.identifier.scopusid | 2-s2.0-85040018687 | - |
dc.identifier.wosid | 000425723700005 | - |
dc.identifier.bibliographicCitation | AMERICAN HEART JOURNAL, v.197, pp.35 - 42 | - |
dc.relation.isPartOf | AMERICAN HEART JOURNAL | - |
dc.citation.title | AMERICAN HEART JOURNAL | - |
dc.citation.volume | 197 | - |
dc.citation.startPage | 35 | - |
dc.citation.endPage | 42 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalWebOfScienceCategory | Cardiac & Cardiovascular Systems | - |
dc.subject.keywordPlus | BARE-METAL | - |
dc.subject.keywordPlus | CLINICAL-TRIAL | - |
dc.subject.keywordPlus | SIROLIMUS | - |
dc.subject.keywordPlus | IMPLANTATION | - |
dc.subject.keywordPlus | ARTERY | - |
dc.subject.keywordPlus | REVASCULARIZATION | - |
dc.subject.keywordPlus | METAANALYSIS | - |
dc.subject.keywordPlus | ANGIOPLASTY | - |
dc.subject.keywordPlus | MULTICENTER | - |
dc.subject.keywordPlus | CATHETER | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.